Who owns RIGEL PHARMACEUTICALS INC?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of RIGL from SEC Form 13F filings across 154 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 154 institutions disclosed 16.4M shares of RIGEL PHARMACEUTICALS INC worth $640.4M — about 88.3% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
154
13F holders
$640.4M
value, 2026 filers
88.3%
of shares outstanding (16.4M sh)
34
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of RIGL's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 1.9M | $75.9M | 0.0% | 10.5% | +9.7% |
| 2 | Soleus Capital Management, L.P. | 1.8M | $72.1M | 2.5% | 9.9% | +18335.0% |
| 3 | ARMISTICE CAPITAL, LLC | 1.7M | $65.4M | 0.8% | 9% | +30.6% |
| 4 | STATE STREET CORP | 1.0M | $40.7M | 0.0% | 5.6% | -7.2% |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 785,107 | $30.7M | 0.0% | 4.2% | +2.7% |
| 6 | AMERICAN CENTURY COMPANIES INC | 741,718 | $29.0M | 0.0% | 4% | +36.2% |
| 7 | LSV ASSET MANAGEMENT | 721,666 | $28.2M | 0.1% | 3.9% | +20.0% |
| 8 | ACADIAN ASSET MANAGEMENT LLC | 591,686 | $23.1M | 0.0% | 3.2% | -11.2% |
| 9 | D. E. Shaw & Co., Inc. | 542,539 | $21.2M | 0.0% | 2.9% | +21.7% |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 483,175 | $18.9M | 0.0% | 2.6% | +9.7% |
| 11 | MARSHALL WACE, LLP | 367,393 | $14.4M | 0.0% | 2% | -38.6% |
| 12 | CM Management, LLC | 250,000 | $9.8M | 6.2% | 1.3% | +6.4% |
| 13 | VANGUARD PORTFOLIO MANAGEMENT LLC | 233,728 | $9.1M | 0.0% | 1.3% | +58.4% |
| 14 | DIMENSIONAL FUND ADVISORS LP | 227,951 | $8.9M | 0.0% | 1.2% | -39.9% |
| 15 | GOLDMAN SACHS GROUP INC | 226,780 | $8.9M | 0.0% | 1.2% | -48.4% |
| 16 | TWO SIGMA INVESTMENTS, LP | 207,578 | $8.1M | 0.0% | 1.1% | -48.8% |
| 17 | NOMURA ASSET MANAGEMENT INTERNATIONAL INC.NEW | 195,000 | $7.6M | 0.0% | 1.1% | new |
| 18 | MORGAN STANLEY | 186,049 | $7.3M | 0.0% | 1% | +88.2% |
| 19 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 154,627 | $6.0M | 0.0% | 0.8% | -12.6% |
| 20 | NORTHERN TRUST CORP | 146,381 | $5.7M | 0.0% | 0.8% | +8.8% |
| 21 | RENAISSANCE TECHNOLOGIES LLC | 145,846 | $5.7M | 0.0% | 0.8% | -56.9% |
| 22 | O'SHAUGHNESSY ASSET MANAGEMENT, LLC | 131,177 | $5.1M | 0.0% | 0.7% | +4.4% |
| 23 | AQR CAPITAL MANAGEMENT LLC | 124,801 | $4.9M | 0.0% | 0.7% | +37.1% |
| 24 | BRIDGEWAY CAPITAL MANAGEMENT, LLCNEW | 124,184 | $4.9M | 0.1% | 0.7% | new |
| 25 | Nuveen, LLC | 123,961 | $4.8M | 0.0% | 0.7% | -63.3% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.